D. E. Shaw & Co., Inc. Embecta Corp. Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Embecta Corp. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 888,897 shares of EMBC stock, worth $13.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

888,897

Previous 1,028,800 13.6%

Holding current value

$13.7 Million

Previous $14.5 Million 27.27%

% of portfolio

0.02%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$12.51 - $20.83 $1.75 Million - $2.91 Million	-139,903 Reduced 13.6%	888,897 $18.5 Million
Q3 2024 Nov 14, 2024	SELL	$11.46 - $16.56 $160,932 - $232,552	-14,043 Reduced 1.35%	1,028,800 $14.5 Million
Q2 2024 Aug 14, 2024	BUY	$10.13 - $14.6 $2.05 Million - $2.95 Million	202,363 Added 24.08%	1,042,843 $13 Million
Q1 2024 May 15, 2024	BUY	$12.35 - $19.33 $1.18 Million - $1.85 Million	95,601 Added 12.83%	840,480 $11.2 Million
Q4 2023 Feb 14, 2024	BUY	$12.87 - $19.09 $2.68 Million - $3.98 Million	208,374 Added 38.84%	744,879 $14.1 Million
Q3 2023 Nov 14, 2023	SELL	$15.0 - $22.17 $632,070 - $934,199	-42,138 Reduced 7.28%	536,505 $8.07 Million
Q2 2023 Aug 14, 2023	BUY	$21.6 - $30.69 $2.03 Million - $2.88 Million	93,788 Added 19.34%	578,643 $12.5 Million
Q1 2023 May 15, 2023	BUY	$23.07 - $32.77 $2.61 Million - $3.7 Million	113,030 Added 30.4%	484,855 $13.6 Million
Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $2.77 Million - $3.89 Million	109,613 Added 41.8%	371,825 $9.4 Million
Q3 2022 Nov 14, 2022	BUY	$24.0 - $33.42 $450,600 - $627,460	18,775 Added 7.71%	262,212 $7.55 Million
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $6.03 Million - $8.12 Million	243,437 New	243,437 $6.16 Million

Others Institutions Holding EMBC

# of Institutions

404

Shares Held

52.4M

Call Options Held

120K

Put Options Held

66.8K

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $892M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account